Insulin sensitivity and carotid intima-media thickness: Relationship between insulin sensitivity and cardiovascular risk study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 33, Issue 6, 2013, Pages 1409-1417

  Kozakova, Michaela ^a   Natali, Andrea ^a   Dekker, Jacqueline ^b   Beck Nielsen, Henning ^c   Laakso, Markku ^d   Nilsson, Peter ^e   Balkau, Beverley ^f   Ferrannini, Ele ^a  

^a UNIVERSITY OF PISA   (Italy)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ODENSE UNIVERSITY HOSPITAL   (Denmark)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e LUND UNIVERSITY   (Sweden)

^f CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

Author keywords

Adipokine; Atherosclerosis; Carotid intima media thickness; Fatty acids; Glucose

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; FATTY ACID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; B SCAN; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; COMMON CAROTID ARTERY; DIABETES MELLITUS; DIET RESTRICTION; DYSLIPIDEMIA; FAT MASS; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HEART RATE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; PULSE PRESSURE; REPEAT PROCEDURE; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ADIPOKINE; ATHEROSCLEROSIS; CAROTID INTIMA-MEDIA THICKNESS; FATTY ACIDS; GLUCOSE;

ADIPOKINES; ADULT; AGE DISTRIBUTION; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CAROTID ARTERY DISEASES; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL, LDL; COHORT STUDIES; FATTY ACIDS; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE TOLERANCE TEST; HUMANS; INCIDENCE; INSULIN RESISTANCE; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEX DISTRIBUTION;

EID: 84879109173     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.112.300948     Document Type: Article

References (44)

1. Bonfeld KE, Tabas I. Insulin resistance, hyperglycemia and atherosclerosis. Cell Metabolism. 2011;14:575-585.
2. DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia. 2010;53:1270-1287.
3. Rask-Madsen C, Li Q, Freund B, Feather D, et al. Loss of insulin signaling in vascular endothelia cells accelerated atherosclerosis in apolipoprotein E null mice. Cell Metab. 2010;11:379-389.
4. Engberding N, San Martín A, Martin-Garrido A, Koga M, Pounkova L, Lyons E, Lassègue B, Griendling KK. Insulin-like growth factor-1 receptor expression masks the antiinflammatory and glucose uptake capacity of insulin in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2009;29:408-415.
5. Tabas I, Tall A, Accili D. The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. Circ Res. 2010;106:58-67.
6. Kaiser N, Sasson S, Feener EP, Boukobza-Vardi N, Higashi S, Moller DE, Davidheiser S, Przybylski RJ, King GL. Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells. Diabetes. 1993;42:80-89.
7. Hedblad B, Nilsson P, Janzon L, Berglund G. Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmö, Sweden. Diabet Med. 2000;17:299-307.
8. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R, Selby JV, Saad MF, Savage P, Bergman R. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation. 1996;93:1809-1817.
9. Laakso M, Sarlund H, Salonen R, Suhonen M, Pyörälä K, Salonen JT, Karhapää P. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb. 1991;11:1068-1076.
10. Agewall S, Fagerbern B, Attvall S, Wendelhag I, Urbanavicius V, Wikstrand J. Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke. 1995;26:956-960.
11. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB, Hutchinson RG. Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke. 1994;25:66-73.
12. Rantala AO, Päivänsalo M, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesäniemi YA. Hyperinsulinemia and carotid atherosclerosis in hypertensive and control subjects. Diabetes Care. 1998;21:1188-1193.
13. Larsson H, Berglund G, Ahrén B. Insulin sensitivity, insulin secretion, and glucose tolerance versus intima-media thickness in nondiabetic postmenopausal women. J Clin Endocrinol Metab. 2003;88:4791-4797.
14. Balletshofer BM, Rittig K, Stock J, Lehn-Stefan A, Overkamp D, Dietz K, Häring HU. Insulin resistant young subjects at risk of accelerated atherosclerosis exhibit a marked reduction in peripheral endothelial function early in life but not differences in intima-media thickness. Atherosclerosis. 2003;171:303-309.
15. Hills SA, Balkau B, Coppack SW, Dekker JM, Mari A, Natali A, Walker M, Ferrannini E; The EGIR-RISC Study (The European Group for the Study of Insulin Resistance; Relationship Between Insulin Sensitivity and Cardiovascular Risk): I. Methodology and objectives. Diabetologia. 2004;47:566-570.
16. Balkau B, Mhamdi L, Oppert JM, Nolan J, Golay A, Porcellati F, Laakso M, Ferrannini E; EGIR-RISC Study Group. Physical activity and insulin sensitivity: the RISC study. Diabetes. 2008;57:2613-2618.
17. Polak JF, Person SD, Wei GS, Godreau A, Jacobs DR Jr., Harrington A, Sidney S, O'Leary DH. Segment-specific associations of carotid intimamedia thickness with cardiovascular risk factors: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Stroke. 2010;41:9-15.
18. Lin HF, Liu CK, Liao YC, Lin RT, Chen CS, Juo SH. The risk of the metabolic syndrome on carotid thickness and stiffness: sex and age specific effects. Atherosclerosis. 2010;210:155-159.
19. Kanters SDJM, Algra A, van Leeuwen MS, Banga JD. Reproducibility of in vivo carotid intima-media thickness measurements. Stroke. 1997;28:665-671.
20. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull W Jr., Rosenfeld ME, Schaffer SA, Schwartz CJ, Wagner WD, Wissler RW. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arterioscler Thromb. 1994;14:840-856.
21. Miller MR, Pereira RI, Langefeld CD, Lorenzo C, Rotter JI, Chen YD, Bergman RN, Wagenknecht LE, Norris JM, Fingerlin TE. Levels of free fatty acids (FFA) are associated with insulin resistance but do not explain the relationship between adiposity and insulin resistance in Hispanic Americans: the IRAS Family Study. J Clin Endocrinol Metab. 2012;97:3285-3291.
22. Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes. 1996;45:988-991.
23. Hotta K, Funahashi T, Bodkin NL, Ortmeyer HK, Arita Y, Hansen BC, Matsuzawa Y. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes. 2001;50:1126-1133.
24. Schianca GP, Castello L, Rapetti R, Limoncini A, Bartoli E. Insulin sensitivity: gender-related differences in subjects with normal glucose tolerance. Nutr Metab Cardiovasc Dis. 2006;16:339-344.
25. Juonala M, Kähönen M, Laitinen T, Hutri-Kähönen N, Jokinen E, Taittonen L, Pietikäinen M, Helenius H, Viikari JS, Raitakari OT. Effect of age and sex on carotid intima-media thickness, elasticity and brachial endothelial function in healthy adults: the cardiovascular risk in Young Finns Study. Eur Heart J. 2008;29:1198-1206.
26. Oram JF, Bornfeldt KE. Direct effects of long-chain non-esterified fatty acids on vascular cells and their relevance to macrovascular complications of diabetes. Front Biosci. 2004;9:1240-1253.
27. Camejo G, Olsson U, Hurt-Camejo E, Baharamian N, Bondjers G. The extracellular matrix on atherogenesis and diabetes-Associated vascular disease. Atheroscler Suppl. 2002;3:3-9.
28. Mathew M, Tay E, Cusi K. Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects. Cardiovasc Diabetol. 2010;9:9.
29. Beltozski J. Leptin and atherosclerosis. Atherosclerosis. 2006;189:47-60.
30. Shimada K, Miyazaki T, Daida H. Adiponectin and atherosclerotic disease. Clin Chim Acta. 2004;344:1-12.
31. Armstrong KA, Hiremagalur B, Haluska BA, Campbell SB, Hawley CM, Marks L, Prins J, Johnson DW, Isbel NM. Free fatty acids are associated with obesity, insulin resistance, and atherosclerosis in renal transplant recipients. Transplantation. 2005;80:937-944.
32. Mas S, Martínez-Pinna R, Martín-Ventura JL, Pérez R, Gomez-Garre D, Ortiz A, Fernandez-Cruz A, Vivanco F, Egido J. Local non-esterified fatty acids correlate with inflammation in atheroma plaques of patients with type 2 diabetes. Diabetes. 2010;59:1292-1301.
33. Taniguchi A, Nakai Y, Fukushima M, et al. Ultrasonographically assessed carotid atherosclerosis in Japanese type 2 diabetic patients: role of nonesterified fatty acids. Metabolism. 2002;51:539-543.
34. Kotani K, Sakane N, Saiga K, Kurozawa Y. Leptin:adiponectin ratio as an atherosclerotic index in patients with type 2 diabetes: relationship of the index to carotid intima-media thickness. Diabetologia. 2005;48:2648-2686.
35. Norata GD, Raselli S, Grigore L, Garlaschelli K, Dozio E, Magni P, Catapano AL. Leptin:adiponectin ratio is an independent predictor of intima media thickness of the common carotid artery. Stroke. 2007;38:2844-2846.
36. Katalinic V, Modun D, Music I, Boban M. 2,2'-Azinobis (3-ethylbenzothiazoline 6-sulfonate; ABTS) and ferric reducing antioxidant power (FRAP) assays. Comp Biochem Physiol C Toxicol Pharmacol. 2005;140:47-52.
37. Borrás C, Sastre J, García-Sala D, Lloret A, Pallardó FV, Viña J. Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic Biol Med. 2003;34:546-552.
38. De Caterina R, Madonna R. Impaired fasting plasma glucose and long-term cardiovascular risk: still a foggy relationship. Eur Heart J. 2010;31:1159-1162.
39. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2004;27(suppl 1):S5-S10.
40. Levitam EB, Song Y, Ford ES, Liu S. Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? Arch Intern Med. 2004;164:2147-2155.
41. Yildiz BO, Haznedaroglu IC. Rethinking leptin and insulin action: therapeutic opportunities for diabetes. Int J Biochem Cell Biol. 2006;38:820-830.
42. Mackinnon AD, Jerrard-Dunne P, Sitzer M, Buehler A, von Kegler S, Markus HS. Rates and determinants of site-specific progression of carotid artery intima-media thickness: the carotid atherosclerosis progression study. Stroke. 2004;35:2150-2154.
43. Koskinen J, Kähönen M, Viikari JS, Taittonen L, Laitinen T, Rönnemaa T, Lehtimäki T, Hutri-Kähönen N, Pietikäinen M, Jokinen E, Helenius H, Mattsson N, Raitakari OT, Juonala M. Conventional cardiovascular risk factors and metabolic syndrome in predicting carotid intima-media thickness progression in young adults: the cardiovascular risk in young Finns study. Circulation. 2009;120:229-236.
44. Kozakova M, Morizzo C, Palombo C, Investigators RISC. Wall tensile stress but not atherosclerotic risk factors predict 3-year carotid intimamedia thickness progression rate in healthy subjects [abstract 2.1]. Artery Research. 2012;6:143.